Drug makers may profit from disease in global warming scourge

on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on
The American Conservation Coalition is partnering with AI and gas firms to support data centers and backing reforms that could fast-track their approvals.
on
While Canada Action claims to be funded by ordinary Canadians, donations only made up 0.5% of its revenue in 2024.
on
Some MPs say the arrangement — which gives Turkish Petroleum 95 percent of revenues on estimated 20 billion barrels of oil — is "illegitimate".
on
Civil society left ‘flying blind’ in the face of large turnout from pharma, oil, and mining groups.